A comparative study of efficacy and safety of Olopatadine and Levocetirizine in seasonal Allergic Rhinitis
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2017, Vol 5, Issue 4
Abstract
Abstract: Allergic rhinitis (AR) is one of the common prevalent diseases representing approximately 20% of the general population. Allergic rhinitis (AR) has a relevant impact on society because of its high prevalence, association with an impaired quality of life and the presence of co-morbidities such as atopy and asthma. The aim is to compare the therapeutic efficacy of Levocetirizine and Olopatadine in the treatment of Seasonal Allergic Rhinitis and to compare their safety in terms of incidence of adverse effects. The study was conducted on 90 patients of seasonal allergic rhinitis attending the Department of ENT, Prathima Institute of Medical Sciences, Nagunur, and Karimnagar. In this study 90 subjects suffering from Seasonal Allergic Rhinitis were included. At the first visit, after clinical evaluation and laboratory investigations (DC Eosinophil, Absolute Eosinophil Count, IgE levels), Olopatadine group: n=45 patients were in this group received Olapatadine 10 mg once daily for 2 weeks.Levocetirizine group:n=45 patients were in this group received Levocetirizine 10 mg once daily for 2 weeks. After 2 weeks, all laboratory investigations were repeated and clinical improvement was assessed in terms of change in TNSS scoring and laboratory parameters. TNSS was considered as primary outcome measure. Among 90 patients, 48 patients (53.33%) were female and 42 patients (46.66%) were male. There was a mean decrease of 294.77 in Absolute Eosinophil Count (AEC) in Olopatadine group in comparison to 176.56 in Levocetirizine group. Serum IgE levels (UI/ml)were measured before and after 2 weeks and the results in Olopatadine group there was a mean reduction of 92.04 (UI/ml)in IgE in comparison to 43.28 (UI/ml)in Levocetirizine group. The individual changes in both the groups were statistically significant (<0.001). Total Nasal Symptom Score [TNSS] was assessed. There was a mean decrease of 3.39 in TNSS in Olopatadine group whereas it was 2.92 in Levocetirizine group. Levocetirizine and Olopatadine have been found effective in symptomatic treatment of allergic rhinitis. However Olopatadine was found to have edge over levocetirizine because Olopatadine additionally suppresses LTs and TXA2 release and PAF formation by reducing arachidonic acid release from membrane phospholipids, probably through interference with phospholipase A2 (PLA2). Both drugs have similar adverse effect profiles. Keywords:Olopatadine, Levocetirizine, Allergic Rhinitis
Authors and Affiliations
Sridhar Rao Boyinapelly, Basani Ramesh Chandra
Keywords
Related Articles
- EP ID EP372145
- DOI -
- Views 40
- Downloads 0
Study of Genotypic Variants of Hepatitis B Virus, Their Viral Load and Correlation with Alanine Aminotransferase Levels in HBsAg Positive Patients
Hepatitis B virus (HBV) is the most common potentially life threatening chronic viral infection affecting millions worldwide. More than 240 million people have chronic HBV liver infections. (serum Alanine amino transfera...
Mode of Delivery and Perinatal Outcome in Early Term and Full Term Deliveries
Abstract: To determine effect of mode of deliveries and gestational age on perinatal outcome. This was Prospective Study at Department of Obstetrics & Gynaecology Zenana Hospital, SMS Medical College, and Jaipur from Mar...
Association of Intron4 VNTR Polymorphism with Essential Hypertension
Abstract: Endothelial nitric oxide synthase (eNOS) is the major enzyme responsible for nitric oxide production and its polymorphisms like exon7 (G to T) is linked to essential hypertension in many ethnic groups. The asso...
Chinese Traditional Medicines Face Crucial Challenges in the New Regulatory Science: Approval and Reflection on Chinese Herbal Medicines
Traditional herbal formulae and conventional plant medicines have been recognized as “new” drugs approved in China and the complementary therapeutics appreciated in the West. With over 2,000 years evidence-based implemen...
Association of 25-Hydroxy Vitamin D Levels with Arterial Stiffness Index in Newly Diagnosed Untreated Hypertensive Patients in Rural Tertiary Care Centre of North India
Abstract: 25-hydroxy vitamin D is considered to be the best indicator of vitamin D status in those with normal renal function and reflects the circulating substrate for the tightly regulated hydroxylation into the active...